| |
|
|
|
|
|
|
|||
|
Blood, Vol. 95 No. 3 (February 1), 2000:
pp. 973-978
IMMUNOBIOLOGY
From the Departments of Dermatology and Pneumology, University of
Freiburg, Germany, and the Institute of General Pathology, University
of Ferrara, Italy.
Eosinophils are major effector cells in cellular inflammatory
conditions such as parasitic infections, atopic diseases, bullous dermatoses, and vasculitis. Biological activities of adenosine triphosphate (ATP) were characterized in human eosinophils and compared
with those of other eosinophil activators such as complement fragment
product C5a, platelet-activating factor (PAF), and
eotaxin. ATP initiated production of reactive oxygen
metabolites, as demonstrated by lucigenin-dependent chemiluminescence.
Furthermore, ATP caused up-regulation of the integrin CD11b. In
addition, fluorescence microscope measurements labeled with
fura-2
(1-[2-(5-carboxy-oxazol-2-yl)-6-aminobenzofuran-5-oxy]-2-(2'-amino-5'-methyl-phenoxy)-ethane-N, N, N, N'-tetraacetic acid, pentaacetoxymethyl ester)
eosinophils in the presence or absence of ethyleneglycotetraacetic acid
(EGTA) indicated that there was Ca++ mobilization from
intracellular stores by ATP. Flow cytometric studies showed transient
actin polymerization upon stimulation with ATP and its stable analogues
adenosine 5'-0-(3-thiotriphosphate) and 2-methylthioadenosine
triphosphate tetrasodium (met-ATP). The reactions induced by ATP were
comparable to those obtained by C5a, PAF, and eotaxin. Production of
reactive oxygen metabolites and actin polymerization after stimulation
with ATP was inhibited by pertussis toxin, which indicated involvement
of receptor-coupled guanine nucleotide-binding proteins
(Gi proteins). In addition, experiments with oxidized ATP
also suggest involvement of P2X receptors in this activation process.
The results show that ATP is a strong activator of eosinophils and has
biological activity comparable to those of the eosinophil chemotaxins
C5a, PAF, and eotaxin. The findings strongly suggest a role of ATP in
the pathogenesis of eosinophilic inflammation as an activator of
proinflammatory effector functions.
(Blood. 2000;95:973-978)
Human eosinophils are considered major effector cells
in a number of inflammatory conditions such as parasitic infections, atopic diseases, bullous dermatoses, or vasculitis.1-3 The
recruitment of eosinophils to sites of inflammation is caused by
various specific and nonspecific agents. The complement fragment
product C5a, the phosphatidylcholin-related molecule
platelet-activating factor (PAF), and the CC-chemokines
eotaxin and RANTES are well-characterized eosinophil
activators.4-6 In addition to chemotaxis, C5a, PAF, eotaxin, and RANTES stimulate eosinophil effector functions such as the
production of reactive oxygen metabolites and up-regulation of
CD11b.7,8
Activation of eosinophilic granulocytes by chemotaxins requires binding
to membrane-spanning ligand-specific receptors.9 These
receptors interact at the intracellular site of the plasma membrane
with pertussis toxin-sensitive or cholera toxin-sensitive heterotrimeric guanine nucleotide-binding proteins (G
proteins).10,11 Activated G proteins (GTP-form) dissociate
into the GTP- ATP is an important mediator in the nervous and cardiovascular
systems.16,17 Neurons, platelets, macrophages, T
lymphocytes, and epithelial and endothelial cells release ATP via
nonlytic pathways.18-25 Since the average cytoplasmatic
concentration fluctuates around 10 mmol/L, any agent causing plasma
membrane damage might also enhance the extracellular concentration of
this nucleotide.26 Moreover, the extracellular ATP
concentration is tightly regulated by hydrolysis through ubiquitous
ecto-ATPases.24 Since inflammatory reactions inhibit ATP
diphosphohydrolase activity, accumulation of extracellular ATP can be
assumed under such conditions.27 In addition to acting on
the nervous and cardiovascular systems, modulating effects of ATP on
immune cell responses have been well documented. ATP modulates
responses of B and T lymphocytes28 and mast
cells.29 Furthermore it causes release of interleukin-1 Materials
Isolation of eosinophils
Actin polymerization The content of filamentous actin was analyzed by flow cytometry with NBD-phallacidin staining.8 Briefly, 50 µL aliquots of stimulated cell suspensions (5 × 105 eosinophils/mL) were withdrawn at the indicated time intervals and fixed in a 7.4% formaldehyde buffer. After 1 hour, eosinophils were mixed with a staining cocktail containing 7.4% formaldehyde, 0.33 µmol/L NBD-phallacidin, and 1 mg/mL lysophosphatidylcholine. The fluorescence intensity was measured by flow cytometry.Intracellular Ca++ measurements Intracellular-free Ca++ was measured in fura-2-labeled cells with a digital fluorescence microscopy unit (Attofluor; Zeiss, Oberkochem, Germany). Briefly, eosinophils were incubated with 2 µmol/L fura-2 for 30 minutes at 37°C in buffer free of Ca++ and Mg++. Cells were washed twice and finally resuspended in the same buffer containing 1.5 mmol/L calcium dichloride and magnesium dichloride. The fluorescence traces after stimulation were followed fluorospectrometrically, and the ratio between absorption at 340 nm and 380 nm was calculated.Lucigenin-dependent chemiluminescence Eosinophils were resuspended to a density of 5 × 104 cells/mL containing 200 µmol/L lucigenin. Measurements were performed in triplicate at 37°C.7 Reactions over a 60-minute time period after cell stimulation were followed and expressed as intensity integral counts.CD11b expression The integrin CD11b was analyzed by flow cytometry with PE-conjugated anti-CD11b mAbs. Eosinophils were stimulated and then incubated for 30 minutes at 37°C. The reaction was stopped by diluting the sample with 100-fold ice-cold buffer. Samples were incubated on ice for 40 minutes with PE-conjugated anti-CD11b mAbs.
Actin response and ATP The influence of ATP on the actin network in eosinophils was analyzed by flow cytometry. This nucleotid caused a rapid and transient polymerization of actin molecules (Figure 1A and B). There was a 50% transient increase of the filament-actin (f-actin) content within 30 seconds. Half-maximum and maximum effects were observed at 0.1 µmol/L and 100 µmol/L concentrations, respectively, and after 300 seconds, the actin content returned to control values. In tissue and cells, ATP can be easily metabolized into various products. To confirm that ATP and not its metabolic products produce this effect, experiments were conducted with ATP and its stable analogues ATP S and met-ATP. Both
ATP and the stable analogues induced a fast and transient actin
polymerization in eosinophils (Table 1).
Mobilization of intracellular Ca++ by ATP Intracellular Ca++ transients were followed in fura-2-labeled eosinophils by digital fluorescence microscopy. ATP induced a rapid and concentration-dependent intracellular response (Figure 2A). In order to analyze whether ATP stimulates mobilization of Ca++ from intracellular stores or influx across the plasma membrane from extracellular medium, measurements were performed in the presence of added EGTA (Figure 2B). Since this Ca++ chelator had no significant effect on the initial magnitude of the response, it appears that ATP mobilizes calcium from intracellular stores. However, EGTA accelerated the recovery to initial values, which also suggests involvement of transmembranous Ca++ fluxes in this response. To analyze participation of P2X receptors in the ATP-induced calcium response, experiments with oxidized ATP, a well-known P2X antagonist, were performed. This agent reduced the time course of the ATP-induced calcium response.
Activation of the respiratory burst Activation of the respiratory burst by ATP was studied by lucigenin-dependent chemiluminescence. These experiments revealed ATP-dependent production of reactive oxygen metabolites in a concentration-dependent manner. Half-maximum and maximum effects were observed at 10 µmol/L and 100 µmol/L concentrations, respectively (Figure 3A). At optimum concentrations, continuous measurements indicated a rapid induction of the response, with maximum values after 5 minutes. In addition, the respiratory burst induced by the stable ATP analogues ATP S and met-ATP showed similar
results (Table 1). Again, to prove participation of P2X receptors in
production of reactive oxygen metabolites, experiments with oxidized
ATP were performed. Production of reactive oxygen metabolites was
partially blocked by preincubation with oxidized ATP (Figure 3B).
CD11b up-regulation by ATP The influence of ATP on the expression of the integrin CD11b was measured by flow cytometry (Figure 4B). ATP induced a concentration-dependent response (Figure 4A). The time course of CD11b expression was very rapid, and half-maximum and maximum effects were seen after 30 seconds and 4 minutes, respectively (data not shown).
Comparison of the activation profiles of different eosinophil stimuli The activation profile of ATP on eosinophils was compared to the responses provoked by other well-defined eosinophil activators such as C5a, PAF, eotaxin, and RANTES. All eosinophil activators that were tested stimulated intracellular Ca++ transients, actin reorganization, respiratory burst, and expression of CD11b in a concentration-dependent manner (data not shown). At optimal concentrations, ATP induced the strongest effects on each parameter (Table 2).
Inhibition of ATP-induced cell response by pertussis toxin Pertussis toxin blocks cell activation that was induced by Gi-protein-coupled receptors.12 Pretreatment of eosinophils with pertussis toxin resulted in a complete block of the ATP-induced chemiluminescence (Figure 5A) and actin response (Figure 5B). In contrast, CD11b translocation (Figure 5C) was only blocked approximately 80%, and Ca++ fluxes (Figure 5D) were inhibited approximately 43%. To demonstrate that eosinophil metabolic activity remained after pertussis toxin treatment, the chemiluminescence response was assumed with PMA. Toxin treatment did not significantly influence the phorbol ester-triggered response (Figure 5A).
Eotaxin, PAF, C5a, and RANTES are well-defined chemotaxins for eosinophils.7 It can be assumed that all these agents are involved at different stages in the accumulation of eosinophils at inflammatory sites. In addition to migration, these chemotaxins stimulate eosinophil effector functions such as the production of reactive oxygen metabolites and the up-regulation of CD11b.7,8 Chemotactic activity of ATP for eosinophils has been described in a previous publication.34 To improve our understanding of the biological activities of ATP, we analyzed various intracellular signal mechanisms and cell effector functions in eosinophils. As could be expected from an agent with chemotactic activity, this study showed that ATP induces a concentration-dependent reorganization of the actin network. The precise mechanisms regulating the actin response are not fully understood; however, it is believed to involve interaction of phospholipids with actin-binding proteins.13 Half-maximum effects of ATP on the actin response were obtained in the low µmol/L range, whereas maximum actin polymerization required a 1000-fold higher concentration of ATP. This reaction is not surprising because it is understood that from receptor binding studies in neutrophils, early actin polymerization requires occupancy of only a couple of receptors, whereas maximum actin reactions require occupancy of almost all expressed receptors.37
The authors gratefully acknowledge the assistance of A. Komann and D. Purlis.
Submitted April 2, 1999; accepted September 29, 1999.
S.D. and M.I. contributed equally to this work.
Supported by grant 01 GC 9701 from the Bundesministerium
f
Reprints: Johannes Norgauer, Department of Dermatology,
Hauptstra
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
1. Bruijnzeel P. Eosinophil tissue mobilization in allergic disorders. Ann Acad Sci. 1994;725:259-267[Medline] [Order article via Infotrieve]. 2. Kay AB. "Helper" (CD4+) T cells and eosinophils in allergy and asthma [review]. Am Rev Respir Dis. 1992;145(suppl 2):S22-S26[Medline] [Order article via Infotrieve]. 3. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol. 1991;88:935-942[Medline] [Order article via Infotrieve]. 4. Weber M, Dahinden CA. Basophil and eosinophil activation by CC chemokines. Int Arch Allergy Immunol. 1995;107:148-150[Medline] [Order article via Infotrieve]. 5. Nagy L, Lee TH, Goetzl EJ, Pickett WC, Kay AB. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol. 1982;47:541-547[Medline] [Order article via Infotrieve]. 6. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor: a potent chemotactic and chemokinetic factor for eosinophils. J Clin Invest. 1986;78:1701-1706.
7.
Tenscher K, Metzner B, Schöpf E, Norgauer J, Czech W.
Recombinant human Eotaxin induces oxygen radical production, Ca2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophiols via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.
Blood.
1996;88:3195-3199 8. Tenscher K, Metzner B, Hartmann M, Schöpf E, Norgauer J. The monocyte chemotatic protein-4 (MCP4) induces oxygen radical production, actin polymerisation and CD11b upregulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem Biophys Res Commun. 1997;240:32-35[Medline] [Order article via Infotrieve]. 9. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today. 1994;15:127-133[Medline] [Order article via Infotrieve].
10.
Gierschik P, Sidiropoulos D, Jakobs KH.
Two distinct Gi-proteins mediate N-formyl-peptide receptor signal transduction in human leukemia (HL-60) cells.
J Biol Chem.
1989;264:21,470-21,473 11. Sozzani S, Luini W, Molino M, et al. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol. 1991;147:2215-2221[Abstract]. 12. Camps M, Carrozzi A, Schnabel P, Scheer P, Parker PJ, Gierschik P. Isozyme-selective stimulation of phospholipase C-beta by G-protein beta-gamma subunits. Nature. 1992;360:684-686[Medline] [Order article via Infotrieve].
13.
Stossel TP.
From signal to pseudopod.
J Biol Chem.
1989;264:18,261-18,264
14.
Elsner J, Oppermann M, Czech W, Kapp A.
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins.
Blood.
1994;83:3324-3331 15. Elsner J, Oppermann M, Czech W, et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol. 1994;24:518-522[Medline] [Order article via Infotrieve]. 16. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-97[Medline] [Order article via Infotrieve]. 17. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 1996;19:13-18[Medline] [Order article via Infotrieve]. 18. Colman R. Aggregin: a platelet ADP receptor that mediates activation. FASEB J. 1990;4:1425-1435[Abstract]. 19. Pearson JD, Gordon JL. Vascular endothelium and smooth muscle cells in culture selectively release adenine nucleotides. Nature. 1979;281:384-386[Medline] [Order article via Infotrieve].
20.
Abraham EH, Pratt AG, Gerweck L, et al.
The multidrug resistance (mdr1) gene product functions as an ATP channel.
Proc Natl Acad Sci U S A.
1993;90:312-316 21. Schwiebert EM, Egan ME, Hwang T-H, et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell. 1995;81:1063-1073[Medline] [Order article via Infotrieve].
22.
Filippini A, Taffs RE, Sitkovsky MV.
Extracellular ATP in T-lymphocyte activation: possible role in effector function.
Proc Natl Acad Sci U S A.
1990;87:8267-8271
23.
Ferrari D, Villalba M, Chiozzi P, Falzoni S, Ricciardi-Castagnoli P, Di Virgilio F.
Purinergic modulation of Interleukin-1 release from microglial cells stimulated with bacterial endotoxin.
J Exp Med.
1997;185:579-582 24. Zimmermann H. Extracellular purine metabolism. Drug Dev Res. 1996;39:337. 25. Todrov LD, Mihaylova-Todrova S, Westfall TD, et al. Neuronal release of soluble nucleotidases and their role in neurotransmitter interactivation. Nature. 1997;387:76-79[Medline] [Order article via Infotrieve]. 26. Di Virgillio F, Chiozzi P, Falzoni S, et al. Cytolytic P2X purinoceptors. Cell Death and Diff. 1998;5:191-199[Medline] [Order article via Infotrieve].
27.
Robson CR, Kaczmarek E, Siegel JB, et al.
Loss of ATP diphosphohydrolase activity with endothelial cell activation.
J Exp Med.
1997;185:153-163 28. Padeh S, Cohen A, Roifman CM. ATP-induced activation of human B lymphocytes via P2 purinoreceptors. J Immunol. 1991;143:1626-1632. 29. Cockcroft S, Gomperts BD. The ATP4- receptor of rat mastcells. Biochem J. 1980;188:789-798[Medline] [Order article via Infotrieve].
30.
Ferrari D, Chiozzi P, Falzoni S, et al.
Extracellular ATP triggers IL-1 31. Gregory S, Kern M. Adenosine and adenine nucleotides are mitogenic for mouse thymocytes. Biochem Biophys Res Commun. 1985;83:1111-1116. 32. Cowen DS, Berger M, Nuttle L, Dubyak GR. Chronic treatment with P2-purinergic receptor agonists induced phenotypic modulation of HL-60 and U937 human myelogenous leukemia cells. J Leukoc Biol. 1991;50:109-122[Abstract]. 33. Ward P, Cunningham TW, McCulloch KK, Johnson KJ. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils. Lab Invest. 1988;58:438-447[Medline] [Order article via Infotrieve].
34.
Burgers JA, Schweizer RC, Koenderman L, Bruijnzeel PLB, Akkerman JWN.
Human platelets secrete chemotactic activity for eosinophils.
Blood.
1993;81:49-55 35. Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today. 1995;16:524-528[Medline] [Order article via Infotrieve]. 36. Di Virgilio F, Ferrari D, Chiozzi P, et al. Purinoceptor function in the immune system. Drug Dev Res. 1996;38:1.
37.
Sklar-LA, Hyslop-PA, Oades-ZG, et al.
Signal transduction and ligand-receptor dynamics in the human neutrophil: transient responses and occupancy-response relations at the formyl peptide receptor.
J Biol Chem.
1985;260:11,461-11,467
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. Myrtek, T. Muller, V. Geyer, N. Derr, D. Ferrari, G. Zissel, T. Durk, S. Sorichter, W. Luttmann, M. Kuepper, et al. Activation of Human Alveolar Macrophages via P2 Receptors: Coupling to Intracellular Ca2+ Increases and Cytokine Secretion J. Immunol., August 1, 2008; 181(3): 2181 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Song, I. Steinebrunner, X. Wang, S. C. Stout, and S. J. Roux Extracellular ATP Induces the Accumulation of Superoxide via NADPH Oxidases in Arabidopsis Plant Physiology, April 1, 2006; 140(4): 1222 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko Activation of human eosinophils via P2 receptors: novel findings and future perspectives J. Leukoc. Biol., January 1, 2006; 79(1): 7 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Muller, H. Bayer, D. Myrtek, D. Ferrari, S. Sorichter, M. W. Ziegenhagen, G. Zissel, J. C. Virchow Jr., W. Luttmann, J. Norgauer, et al. The P2Y14 Receptor of Airway Epithelial Cells: Coupling to Intracellular Ca2+ and IL-8 Secretion Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Ryu, K. H. Hong, J. H. Maeng, J.-B. Kim, J. Ko, J. Y. Park, K.-U. Lee, M. K. Hong, S. W. Park, Y. H. Kim, et al. Overexpression of Uncoupling Protein 2 in THP1 Monocytes Inhibits {beta}2 Integrin-Mediated Firm Adhesion and Transendothelial Migration Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 864 - 870. [Abstract] [Full Text] |
||||
![]() |
M. Idzko, M. Laut, E. Panther, S. Sorichter, T. Durk, J. W. Fluhr, Y. Herouy, M. Mockenhaupt, D. Myrtek, P. Elsner, et al. Lysophosphatidic Acid Induces Chemotaxis, Oxygen Radical Production, CD11b Up-Regulation, Ca2+ Mobilization, and Actin Reorganization in Human Eosinophils via Pertussis Toxin-Sensitive G Proteins J. Immunol., April 1, 2004; 172(7): 4480 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Panther, S. Corinti, M. Idzko, Y. Herouy, M. Napp, A. la Sala, G. Girolomoni, and J. Norgauer Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells Blood, May 15, 2003; 101(10): 3985 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sak, J.-M. Boeynaems, and H. Everaus Involvement of P2Y receptors in the differentiation of haematopoietic cells J. Leukoc. Biol., April 1, 2003; 73(4): 442 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. PANTHER, M. IDZKO, Y. HEROUY, H. RHEINEN, P. J. GEBICKE-HAERTER, U. MROWIETZ, S. DICHMANN, and J. NORGAUER Expression and function of adenosine receptors in human dendritic cells FASEB J, September 1, 2001; 15(11): 1963 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. la Sala, D. Ferrari, S. Corinti, A. Cavani, F. Di Virgilio, and G. Girolomoni Extracellular ATP Induces a Distorted Maturation of Dendritic Cells and Inhibits Their Capacity to Initiate Th1 Responses J. Immunol., February 1, 2001; 166(3): 1611 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood, February 1, 2001; 97(3): 587 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Meerschaert, W. W. Busse, P. J. Bertics, and D. F. Mosher CD14+ Cells Are Necessary for Increased Survival of Eosinophils in Response to Lipopolysaccharide Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 780 - 787. [Abstract] [Full Text] |
||||
![]() |
D. FERRARI, A. LA SALA, P. CHIOZZI, A. MORELLI, S. FALZONI, G. GIROLOMONI, M. IDZKO, S. DICHMANN, J. NORGAUER, and F. DI VIRGILIO The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release FASEB J, December 1, 2000; 14(15): 2466 - 2476. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2000 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||